Literature DB >> 7743597

Visceral leishmaniasis in HIV-infected patients in the south of France.

J Dereure1, J Reynes, F Pratlong, I Lamaury, J A Rioux, F Janbon, J P Dedet.   

Abstract

Between 1989 and 1993, investigations by classical parasitological procedures of 139 HIV-infected adults living in visceral leishmaniasis (VL) endemic areas showed that 10 of them (7.2%) were positive for Leishmania (by stained smears and culture). In the same period we identified 15 VL cases in patients not infected with HIV. Thus, 40% (10/25) of our VL cases were associated with HIV infection.

Entities:  

Mesh：

Year:  1995        PMID： 7743597      PMCID： PMC2486745     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


  2 in total

1.  Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature.

Authors:  J Altés; A Salas; M Riera; M Udina; A Galmés; J Balanzat; A Ballesteros; J Buades; F Salvá; C Villalonga
Journal:  AIDS       Date:  1991-02       Impact factor: 4.177

Review 2.  Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification.

Authors:  J A Rioux; G Lanotte; E Serres; F Pratlong; P Bastien; J Perieres
Journal:  Ann Parasitol Hum Comp       Date:  1990
  2 in total
  8 in total

1.  Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model.

Authors:  M Paul; R Durand; H Fessi; D Rivollet; R Houin; A Astier; M Deniau
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.

Authors:  J P Gangneux; A Sulahian; Y J Garin; R Farinotti; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  Optimized PCR using patient blood samples for diagnosis and follow-up of visceral Leishmaniasis, with special reference to AIDS patients.

Authors:  L Lachaud; J Dereure; E Chabbert; J Reynes; J M Mauboussin; E Oziol; J P Dedet; P Bastien
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 4.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients.

Authors:  C Amela; D López-Gay; J C Alberdi; J Castilla
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

6.  Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain.

Authors:  J A Pineda; J A Gallardo; J Macías; J Delgado; C Regordán; F Morillas; F Relimpio; J Martín-Sánchez; A Sánchez-Quijano; M Leal; E Lissen
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 7.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

8.  Haemoculture as a tool for diagnosing visceral leishmaniasis in HIV-negative and HIV-positive patients: interest for parasite identification.

Authors:  J Dereure; F Pratlong; J Reynes; D Basset; P Bastien; J P Dedet
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.